Antiretroviral therapy response among HIV-2 infected patients: a systematic review
Authors:
Open Access
- 26 August 2014
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 1-16
Abstract
Few data are available on antiretroviral therapy (ART) response among HIV-2 infected patients. We conducted a systematic review on treatment outcomes among HIV-2 infected patients on ART, focusing on the immunological and virological responses in adults. Data were extracted from articles that were selected after screening of PubMed/MEDLINE up to November 2012 and abstracts of the 1996–2012 international conferences. Observational cohorts, clinical trials and program reports were eligible as long as they reported data on ART response (clinical, immunological or virological) among HIV-2 infected patients. The determinants investigated included patients’ demographic characteristics, CD4 cell count at baseline and ART received. Seventeen reports (involving 976 HIV-2 only and 454 HIV1&2 dually reactive patients) were included in the final review, and the analysis presented in this report are related to HIV-2 infected patients only. There was no randomized controlled trial and only two cohorts had enrolled more than 100 HIV-2 only infected patients. The median CD4 count at ART initiation was 165 cells/mm3, [IQR; 137–201] and the median age at ART initiation was 44 years (IQR: 42–48 years). Ten studies included 103 patients treated with three nucleoside reverse transcriptase inhibitors (NRTI). Protease inhibitor (PI) based regimens were reported by 16 studies. Before 2009, the most frequent PIs used were Nelfinavir and Indinavir, whereas it was Lopinavir/ritonavir thereafter. The immunological response at month-12 was reported in six studies and the mean CD4 cell count increase was +118 cells/μL (min-max: 45–200 cells/μL). Overall, clinical and immuno-virologic outcomes in HIV-2 infected individuals treated with ART are suboptimal. There is a need of randomized controlled trials to improve the management and outcomes of people living with HIV-2 infection.Keywords
This publication has 49 references indexed in Scilit:
- Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort StudyPLOS ONE, 2013
- HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West AfricaPLOS ONE, 2011
- Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource SettingsAIDS Research and Treatment, 2011
- Emergence of Multiclass Drug–Resistance in HIV‐2 in Antiretroviral‐Treated Individuals in Senegal: Implications for HIV‐2 Treatment in Resouce‐Limited West AfricaClinical Infectious Diseases, 2009
- A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West AfricaAIDS, 2008
- HIV Type 2 Protease, Reverse Transcriptase, and Envelope Viral Variation in the PBMC and Genital Tract of ARV-Naive Women in SenegalAIDS Research and Human Retroviruses, 2008
- Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg databaseBMC Infectious Diseases, 2008
- Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in FranceAIDS, 2008
- Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea–BissauEpidemiology and Infection, 2007
- Direct Evidence of Lower Viral Replication Rates In Vivo in Human Immunodeficiency Virus Type 2 (HIV-2) Infection than in HIV-1 InfectionJournal of Virology, 2007